BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26927686)

  • 21. Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition.
    El-Husseiny WM; El-Sayed MA; El-Azab AS; AlSaif NA; Alanazi MM; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):744-758. PubMed ID: 32183576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
    Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
    Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
    Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
    Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
    Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
    Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis.
    Lu XY; Wang ZC; Ren SZ; Shen FQ; Man RJ; Zhu HL
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3491-8. PubMed ID: 27349331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2 Docking Structural Analysis with Phytochemical Extracts of Rosemary: A Possible Cytotoxicity on Head and Neck Squamous Cell Carcinoma Cell Line (HEp-2).
    Abd El-Hamid IS; Mouselhy YY; El-Shafei MM; Sayed MM; Mohamed AF; Farag DB
    Anticancer Agents Med Chem; 2019; 19(12):1473-1480. PubMed ID: 31244433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents.
    Özdemir A; Gökbulut S; Sever B; Çiftçi GA; Altıntop MD
    Anticancer Agents Med Chem; 2018; 18(10):1394-1404. PubMed ID: 29210665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. myo-Inositol esters of indomethacin as COX-2 inhibitors.
    Kadirvel M; Abudalal AS; Rajendran R; Gbaj A; Demonacos C; Freeman S
    Carbohydr Res; 2012 Jul; 355():13-8. PubMed ID: 22578527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylene-bearing sulfur-containing cyanopyrimidine derivatives for treatment of cancer: Part-II.
    Akhtar W; Nainwal LM; Kaushik SK; Akhtar M; Shaquiquzzaman M; Almalki F; Saifullah K; Marella A; Alam MM
    Arch Pharm (Weinheim); 2020 May; 353(5):e1900333. PubMed ID: 32115728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents.
    Akhtar W; Verma G; Khan MF; Shaquiquzzaman M; Rana A; Anwer T; Akhter M; Alam MM
    Mini Rev Med Chem; 2018; 18(4):369-379. PubMed ID: 28486908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Novel 2-Amino-5-(Substituted)-1,3,4-Thiadiazole Derivatives: New Utilities for Colon Cancer Treatment.
    Raj V; Rai A; Singh AK; Keshari AK; Trivedi P; Ghosh B; Kumar U; Kumar D; Saha S
    Anticancer Agents Med Chem; 2018; 18(5):719-738. PubMed ID: 28425852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New paracetamol hybrids as anticancer and COX-2 inhibitors: Synthesis, biological evaluation and docking studies.
    Alam MM; Alsenani NI; Abdelhamid AA; Ahmad A; Baothman OA; Hosawi SA; Altayeb H; Nadeem MS; Ahmad V; Nazreen S; Elhenawy AA
    Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300340. PubMed ID: 37880869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking.
    El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Asiri YA; Abdel-Aziz AA
    Eur J Med Chem; 2018 Oct; 158():134-143. PubMed ID: 30216848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COX inhibitors Indomethacin and Sulindac derivatives as antiproliferative agents: synthesis, biological evaluation, and mechanism investigation.
    Chennamaneni S; Zhong B; Lama R; Su B
    Eur J Med Chem; 2012 Oct; 56():17-29. PubMed ID: 22940705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors.
    Scholz M; Blobaum AL; Marnett LJ; Hey-Hawkins E
    Bioorg Med Chem; 2012 Aug; 20(15):4830-7. PubMed ID: 22748709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.
    Rayar AM; Lagarde N; Martin F; Blanchard F; Liagre B; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitía M
    Eur J Med Chem; 2018 Feb; 146():577-587. PubMed ID: 29407982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.